Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Vaccines Represent ‘Vital Early Weapon’ For Next Ebola Outbreak

The Lancet Global Health: Ebola vaccines: an uncertain future? Zoë Mullan, editor of The Lancet Global Health “…The rapid roll-out of these [Ebola vaccine] trials has been tremendously impressive. … Vaccines are not a magic bullet. Nothing can replace the basic tenets of public health epidemiology and community mobilization. But…

GHIT Joins Gates Foundation In Grand Challenge Against NTDs, Pledges Initial $4M For Drug, Vaccine Development

SciDev.Net: Japan joins Gates’s Grand Challenge on tropical diseases “The Gates Foundation and Japan [on Thursday] launched a Grand Challenge to tackle neglected diseases, with an initial funding pledge of U.S. $4 million supplied jointly with Japanese companies. … The Tokyo-based Global Health Innovative Technology (GHIT) Fund, of which the [Gates…

UCSF Releases Paper On Private Health Sector’s Role In Malaria Surveillance

UCSF Global Health Sciences: Background Paper: The Private Sector’s Role in Malaria Surveillance UCSF Global Health Sciences Global Health Group published a background paper “synthesizing current research and expert knowledge on the current state of the private health sector’s role in malaria surveillance. [The paper discusses] key challenges and how…

Experimental Ebola Vaccine Safe, Elicits Immune Response, Researchers Say

Agence France-Presse: Ebola vaccine is safe, researchers say “Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the U.S. National Institutes of Health suggest it is safe for use, researchers said Wednesday…” (1/28). Press Association/The Guardian: Cautious optimism follows results from trials of early…

Experts Debate Role Of Public-Private Partnerships In Vaccine, Drug Development

GroundTruth Project/GlobalPost: In Ebola response, Big Pharma and public sector strive to make up for lost time “…The delayed response [to Ebola] is an example of the diverging interests of public and private sectors when it comes to addressing a public health crisis, say experts from both sides. … Still,…

Asia’s Largest Vaccine Maker Developing Low-Cost HPV, Diarrheal, Pneumococcal Vaccines

Bloomberg Businessweek: Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health “…Serum Institute of India Ltd., which makes vaccines injected in 65 percent of the world’s children, is targeting newer vaccines, including one for the human papillomavirus that could be available in late 2018 and sell at a third of…